Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Life Sciences|January 1, 1993
A potent and long-acting NK-1 selective agonistN Rouissi, D Jukic, P D'Orléans-Juste, et al.Life Sciences|January 1, 1991
Neurokinin receptors antagonists: old and newD Jukic, N Rouissi, R Laprise, et al.Canadian Journal of Physiology and Pharmacology|July 1, 1991
Characterization of bradykinin receptors in peripheral organsN E Rhaleb, N Rouissi, G Drapeau, et al.Journal of Cardiovascular Pharmacology|September 1, 1991
Pharmacological evaluation of the angiotensin, kinin, and neurokinin receptors on the rabbit vena cavaF Nantel, N Rouissi, N E Rhaleb, et al.Hypertension (Dallas, Tex. : 1979)|April 1, 1991
DuP 753 is a specific antagonist for the angiotensin receptorN E Rhaleb, N Rouissi, F Nantel, et al.British Journal of Pharmacology|March 1, 1990
Structure-activity studies on bradykinin and related peptides: agonistsN E Rhaleb, G Drapeau, S Dion, et al.Life Sciences|January 1, 1993
Substance P (NK-1 receptor) antagonists: in vivo and in vitro activities in rats and guinea pigsN Rouissi, A Claing, M Nicolau, et al.Pharmacology|January 1, 1990
Inhibitors of peptidases: how they influence the biological activities of substance P, neurokinins, bradykinin and angiotensin in guinea pig, hamster and rat urinary bladdersN Rouissi, F Nantel, G Drapeau, et al.Regulatory Peptides|November 15, 1990
Antagonists for the neurokinin NK-3 receptor evaluated in selective receptor systemsG Drapeau, N Rouissi, F Nantel, et al.Pharmacology|January 1, 1990
Inhibitors of peptidases: how they influence the biological activities of substance P, neurokinins, kinins and angiotensins in isolated vesselsN Rouissi, F Nantel, G Drapeau, et al.Pageof 3